(+/-)-tricyclo<3.3.1.1^3,7>dec-1-yl<1-(1H-indol-3-ylmethyl)-1-methyl-2-oxo-2-<(2-phenylethyl)amino>ethyl>carbamate | 129397-55-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: (+/-)-tricyclo<3.3.1.1^3,7>dec-1-yl<1-(1H-indol-3-ylmethyl)-1-methyl-2-oxo-2-<(2-phenylethyl)amino>ethyl>carbamate
• 英文别名: 1-adamantyl N-[3-(1H-indol-3-yl)-2-methyl-1-oxo-1-(2-phenylethylamino)propan-2-yl]carbamate
• CAS: 129397-55-3
• 化学式: C₃₁H₃₇N₃O₃
• 分子量: 499.653
• InChiKey: QANHFWCJJLKZFE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.2
• 重原子数：
  37
• 可旋转键数：
  9
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.48
• 拓扑面积：
  83.2
• 氢给体数：
  3
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  Alpha-甲基-DL-色氨酸 在 碳酸氢钠 、 1-羟基苯并三唑 、 N,N'-二环己基碳二亚胺 作用下， 以 1,4-二氧六环 为溶剂， 反应 0.5h， 生成 (+/-)-tricyclo<3.3.1.1^3,7>dec-1-yl<1-(1H-indol-3-ylmethyl)-1-methyl-2-oxo-2-<(2-phenylethyl)amino>ethyl>carbamate
  参考文献：
  名称：

  α-Methyl tryptophanylphenylalanines and their arylethylamine “dipeptoid” analogues of the tetrapeptide cholecystokinin (30–33)

  摘要：

  DOI：

  10.1016/0223-5234(90)90164-x

文献信息

• Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and mixed CCK-A/CCK-B antagonists
  作者：P. R. Boden、M. Higginbottom、D. R. Hill、D. C. Horwell、J. Hughes、D. C. Rees、E. Roberts、L. Singh、N. Suman-Chauhan、G. N. Woodruff

  DOI：10.1021/jm00057a005

  日期：1993.3

  The design, synthesis, and structure-activity relationships (SAR) for the development of selective dipeptoid ligands for both of the cholecystokinin (CCK) receptor subtypes CCK-A and CCK-B are described. The SAR developed is used to design a ligand with equal nanomolar binding affinity for both the CCK-A and CCK-B receptors. Example compounds such as [1R-[1 alpha[R*(R*)],2 beta]]-4-[[2-[[3-(1H-indol-3-yl)-

  描述了开发胆囊收缩素（CCK）受体亚型CCK-A和CCK-B的选择性二肽配体的设计，合成和结构活性关系（SAR）。开发的SAR用于设计对CCK-A和CCK-B受体均具有相同纳摩尔结合亲和力的配体。示例化合物，例如[1R- [1 alpha [R *（R *）]，2 beta]]-4-[[2-[[3-（1H-吲哚-3-基）-2-甲基-2- [[[（（2-甲基环己基）氧基]羰基]氨基] -1-氧丙基]-氨基] -1-苯基乙基]氨基] -4-氧代丁酸（24c），（1R-反式）-N-α -甲基-N-[[（（2-甲基环己基）氧基]羰基] -D-色氨酸] -L-3-（苯甲基）-β-丙氨酸（28i）和N- [α-甲基-N-[（三环） [3.3.1.1]癸-2-基氧基）羰基] -D-色氨酸] -L-3-（苯甲基）-β-丙氨酸（30m）是具有CCK-B结合亲和力为IC50 = 3.9的CCK-B选择性化合物，
• Rationally designed ‘dipeptoid’ analogues of cholecystokinin (CCK): N-terminal structure-affinity relationships of α-methyl-tryptophan derivatives
  作者：JM Eden、M Higginbottom、DR Hill、DC Horwell、JC Hunter、K Martin、MC Pritchard、SS Rahman、RS Richardson、E Roberts

  DOI：10.1016/0223-5234(93)90077-r

  日期：1993.1

  The structure-affinity relationships (SAR) between the N-terminii of a series of alpha-methyl-tryptophanylphenethylamide derivatives and the cholecystokinin (CCK) B receptor are discussed. A series of compounds with the general formula R-X-alpha-methyl-tryptophanylphenethylamide was prepared, where R is a cycloalkyl, a bicycloalkyl or a tricycloalkyl group and X is a urethane, thiourethane, amide, urea or a sulphinamide linking group. The CCK-B receptor binding affinities of these are discussed. The SAR form part of a systematic program for the rational design of 'dipeptoid' analogues of the neuropeptide CCK. Beginning with 1,1-dimethylpropyl (+/-)-[1-(1H-indol-3-ylmethyl)-1-methyl-2-oxo-2-[(2-phenylethyl)amino]ethyl]carbamate (IC50 = 4720 nM on CCK-B binding affinity) the N-terminal moiety was systematically changed for groups of varying size, shape and lipophilicity until the optimal N-terminal group was obtained and the favoured linking group chosen, resulting in the compound tricyclo[3.3.1.1(3,7)]dec-2-yl(R)-[(1H-indol-3-ylmethyl)-1-methyl-2-oxo-2-[(2-phenylethyl)amino]ethyl]carbamate with an IC50 = 32 nM on CCK-B receptor binding affinity.
• HORWELL, DAVID C.;BIRCHMORE, BARBARA;BODEN, PHILLIP R.;HIGGINBOTTOM, MICH+, EUR. J. MED. CHEM., 25,(1990) N, C. 53-60
  作者：HORWELL, DAVID C.、BIRCHMORE, BARBARA、BODEN, PHILLIP R.、HIGGINBOTTOM, MICH+

  DOI：——

  日期：——